MedPath

Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test

Completed
Conditions
Sars-CoV2
COVID
Interventions
Diagnostic Test: Vaginal fluid Covid-19 PCR test
Registration Number
NCT04437940
Lead Sponsor
Acibadem University
Brief Summary

Aim of the study is to investigate whether the Covid-19 is found in the vaginal swab samples of female patients diagnosed with covid-19, to evaluate the presence of Covid-19 and the risk of transmission of Covid-19 by intercourse or vaginal delivery.

Detailed Description

Vaginal Covid-19 will be tested by taking vaginal swabs from female patients whose clinical findings are compatible with Covid-19 in Acıbadem Maslak Hospital. In patients with positive vaginal Covid-19 test, vaginal Covid-19 will be re-evaluated for the assessment of viral clearance.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
38
Inclusion Criteria
  • Women who are positive nasofarengeal Covid-19 PCR test result
  • Women who are 18 years or older
  • Women who had sexual intercourse before
Exclusion Criteria
  • who had medical treatment for Covid-19

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Covid-19 positive womenVaginal fluid Covid-19 PCR testWomen with nasofarangeal Covid-19 PCR test is positive
Primary Outcome Measures
NameTimeMethod
Vaginal fluid Covid-19 PCR test result1 month

Vaginal fluid Covid-19 test positivity rate for patients whose nasofarengeal test is positive

Secondary Outcome Measures
NameTimeMethod
becoming negative from positive2 month

The ratio of negative test results to previous positive results for vaginal fluid Covid-19 test

Trial Locations

Locations (1)

Acibadem Maslak Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath